Antifibrotic Effect of Apremilast in Systemic Sclerosis Dermal Fibroblasts and Bleomycin-Induced Mouse Model

The authors conducted experiments focusing on the antifibrotic and anti-inflammatory effects of apremilast using dermal fibroblasts derived from patients with systemic sclerosis and an systemic sclerosis mouse model.
[Scientific Reports]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News